The momentum behind GLP-1 receptor agonists has become impossible to ignore. Originally developed to control blood glucose in diabetes, these therapies have surged to the forefront of obesity care, ...

VectorY Therapeutics has appointed Jessica Atkinson as Chief Business Officer. In this newly created role, she will support ...

This year’s NHS ConfedExpo took place on 11–12 June at Manchester Central, bringing together around 9000 attendees. Among ...